@article{article, title = {{Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12}},
publisher = {{The Endocrine Society}},
url = {{http://dx.doi.org/10.1210/clinem/dgae611 }},
year = {{2024}},
month = {{9}},
author = {{Langdahl B and Chung Y-S and Plebanski R and Czerwinski E and Dokoupilova E and Supronik J and Rosa J and Mydlak A and Rowi艅ska-Osuch A and Baek K-H and Urboniene A et al}},
doi = {{10.1210/clinem/dgae611}},
journal = {{The Journal of Clinical Endocrinology & Metabolism}},
note = {{Accessed on 2025/07/12}}}